<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 74 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page73.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=74">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 74 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 74</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=74"><img src="../thumb/74.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Central Nervous System - 1.7.1                                                  2020-04 / 43
       dyston., gait abnormal., headache, myoclon., hyperkines., syncope,   Indications: Monother./combinat.ther.with levodopa in idiopath.  in major psychot.disords., poss. dos.adjustm.if HRT stopp./introd.dur.
       excess. dayt. somnol., conjunctivit., tinnit., CF, dyspn., rhinit., sinusit.,   Parkinson’s dis.  treatm., withdr.grad.accord.to manufact. instruct., sev.ren./hepat.im-
       hiccups, GI disturbs., tooth dis., skin reacts., sweat., arthrit., bursit.,   (S4) TABS, 43/5.4.1/0624, 0623, 0625  pairm., poss.sympt. complex resembl.neurolept.syndr.report.in assoc.
       leg cramps, myasth., twitch., urin.freq./incont., impot., asthen., ac-  719844-001: 0,125 mg, 100, R323,45  with rapid dos. reduct./ withdr./changes in anti-Parkinson.ther., retro-
       cid. inj., chest pain, fatig., malaise, fev., oed., hallucinat. & confus.  719843-001: 0,25 mg, 100, R309,43  periton. fibros./ pulm. infiltr./pleur.effus.& thicken.report.in some pts.
       esp.in elderly, drowsin. potent., vis. impairm.incl.diplop., hypersens.,   719845-001: 1,0 mg, 100, R1 297,22  with ergot-deriv.dopaminerg.agents., potent. signif.of retin.degenerat.
       orthostat. hypotens.          Dosage: Swall.with water. Admin.dly.dos.in 3 equal. div.dos. Init:   observ.pre-clinic. in albino rats in 2 yr. study not est., bind. to melanin
                                                       nd
       Warnings and special precautions: Safety & effic. in childr.und.   0,125 mg 3x/day incr.to 0,25 mg 3x dly in 2  wk & 0,5 mg 3x/day   contain.tiss., lact.intol.
       18 yrs./pregn.& lactat. not est., ren.impairm., elderly, alert.dr.if pregn.  in 3  wk. accord.to respons. Maint: Indiv.dos.should be in range   Drug interactions: Poss.addit.effs.of CNS depress. & alcoh., con-
                                       rd
       occurs/ intend. becom.pregn.dur.ther., poss.excret.in breast milk,   of 0,375 mg to max.of 4,5 mg/day. Dly.dos. may be incr.if need.by   com.neurolept.& other centr. act.dopamine antag.dimin.eff., metabol.
       avoid antipsychot., concom.other antiparkins. meds., warn pts.of poss.  0,75 mg at wkly.interv.to max. 4,5 mg dly. Incid.of somnol.incr.at dos.  by cytochrome P450 enzyme CYP1A2 poss. interact.. with substrates
       orthostat. hypotens. esp.dur.dos.escalat., poss.neurolept. malign. syn-  high. than 1,5 mg/day. Treatm.discont: Taper dos.off over several   (e.g.theophyll.)or inhibit. (e.g. ciprofloxacin) of this enzyme, incr. plas-
       dr. risk with abrupt withdr., reg. ophthalmolog.monit./if vis.abnorm.,   days. Concom.levodopa ther: Reduc. levodopa dos.grad.dur.both   ma conc.with oestrog.
       fall.asleep. dur. dly. liv.activ., re-assess.pts.reg.for drowsin.& sleep-  dos.escalat.& maint. treatm.until optim.respons.achiev.
       in., pt.to be advis.of drowsin.potent. bef.init. treatm., concom.sedat.  Contraindications: Childr.bel.18 yrs., safety in pregn.& lactat.  SINEMET 25/250, MSD [P/S]
       meds./exist.sleep disords. & concom. meds.incr.pramipexole plasma   not est.  Carbidopa 25 mg, levodopa 250 mg.
       lev., fall. asleep episod.poss.not elimin.by dos.reduct., poss. ther. dis-  Side effects: Somnol., GI disturbs., CNS effs., insomn., dizzin., as-  Indications: Parkinson.dis.& syndr.
       cont.if signif.dayt.sleepin.esp.dur.activ. requir. act.particip., decr.dos.if   then., accid.inj., extrapyramid. syndr., headache, confus., hallucinat.,   (S4) TABS. F/5.4.1/56.
       dopaminerg.S/E of levodopa potent./exacerb.pre-exist.dyskines., BP   oed., malaise, fev., syncope, post.hypotens., vasodilat., hypertens.,   764086-006: 100, R644,16
       monit. esp. in CV dis.& when init.ther., withdr. grad., cont.mannitol  tachycard., chest pain, dry mouth, naus., constip., anorex., dysphag.,   Dosage: Indiv. Init: ½-tab.1-2xdly. incr.by ½ tab. dly./altern.days as
       Drug interactions: Eff.poss.diminish.by dopamine antagonist.,   abdom./back/ neck pain, leg cramps, twitch., trem., hyperton., decr.   necess.till optim.respons.with max.of 8 tabs.dly.
       elimin.decr./half-life incr. with cimetidine, poss.addit.effs.of CNS   libido, depress., anx., atax., hypokines., paralys., paraesthes., gait ab-  SINEMET 25/100, [P/S]
       depress.& alcoh., poss.incr.levodopa plasma conc.& dyskines. exac-  normal., vertigo, skin reacts., sweat., impot., UTI, urin.freq./incont.,   Carbidopa 25 mg, levodopa 100 mg.
       erbat., clear.decr.by drugs secret.by cation. transp. syst., poss.potent   rhinit., dyspn., sinusit., flu syndr., pharyngit., incr. cough, allerg.react.,   (S4) TABS. P/5.4.1/141.
       levodopa dopaminerg. S/E.     infect., voice alter., conjunctivit., incr.saliva, arthrit., arthralg., myalg.,   764078-003: 100, R470,94
                                                                  Dosage: Indiv. Init: 1 tab.3xdly. incr.by 1 tab.dly./altern.days as
       PEXOLA, Ing.Pharm [P/S]       apathy, pneum., tooth disord., periph.oed., fall. asleep without warn.  necess.till max. 8 tabs dly.
       Pramipexole dihydrochlor. monohydr.  Special precautions: Alert dr.in case pregn. occurs/ pregn.plann.  SINEMET CR TABS, [P/S]
       Indications: Monother./combinat.ther.with levodopa in idiopath.Par-  dur.ther., may be excret.in breast milk, fall.asleep.dur.dly.liv.activ.,   Anhydr.carbidopa 50 mg, levodopa 200 mg.
       kinson’s, Immed.Rel.Tabs also: idiopath.restless legs.syndr.  re-assess. pts. reg.for drowsin.& sleepin., pt.to be advis.of drowsin.   (S4) CR TABS. Y/5.4.1/279.
       (S4) IMMED.REL.TABS, [P/S] 32/5.4.1/0298, 0299, 0300  potent.bef.init.treatm., concom.sedat. meds./ exist.sleep disords.&   794635-008: 100, R747,73
       898836-007: 0,125 mg, 100, R471,14  concom.meds.incr. pramipexole plasma lev., poss.ther.discont.if sig-  Dosage: Do not crush/chew.
       898848-008: 0,25 mg, 100, R934,82  nif. dayt.sleepin.esp.dur.activ.requir.act. particip./ potent.danger.ac-  Pts.not receiv.levodopa: Mild to mod.dis: Init. 1 tab 2-3xdly.
       898828-012: 1 mg, 100, R1 764,50  tiv., dos.reduct.may not reduc. fall.asleep episod., concom.other anti-  Levodopa not to exceed 600 mg/ day nor interv.of less than 6 hrs.
       Dosage: Admin.with/without food. Ren.impairm: Refer to manu-  parkinson. meds., ren.funct.impairm (see prod.lit. for dos. guidelin.).,   Curr.levodopa/decarboxylase inhibit. combinat.therapy: Sub-
       fact.lit.for dos.adjustm.     withdr.grad., reg.ophthalmolog. monit. in case of vis.abnorm., warn.  stit.dos.to prov. approx. 10-30% more levodopa/day. Interv.betw.dos.
       Parkinson’s dis: Admin.dly.dos.in 3 equal.div. dos. Init. 0,375 mg/  pts.of poss. orthostat. hypotens./hallucinat./confus., caut.pts. against   of 4-8 hrs.of waking day. For substitut.guide see manufact. prod.lit.
       day incr.every 5-7 days depend. on tol. Titrat.to max.therap.eff.   rising rapid.aft.sitt./lying down for long per. esp.at treatm.init./dos.  Curr.levodopa alone therapy: Discont. levodopa 8 hrs.prev. Mild
       Recomm. dly.dos. sched: Wk 1: 0,375 mg/ day, wk.2: 0,75 mg/day,   escalat., elderly, poss. cause/ exacerbat.of pre-exist.dyskines., admin.   to mod.dis: Init. 1 tab 2-3xdly.
       wk 3: 1,50 mg/day. If furth dos.incr.necess.incr. dly.dos.by 0,75 mg   with food poss.reduc.naus., patholog.chang.in retina of albino rats,   Titrat: Aft.init.titrate dos.to therapeut.respons. Most pts.adeq.treat.
       at wkly.interv.to max.of 4,5 mg/ day. Dos.high.than 1,5 mg/day incr.  poss.neurolept.malign.syndr. with abrupt withdr., sev.CV dis., monit.  with 2-8 tabs/day in div. dos.at 4-12 hr.interv.
       somnol.incid. In concom.ther.reduc.levodopa dos. both dur.escalat.   BP esp.init., ren. insuffic.  Contra-indications: MAOI, narr.angle glauc., melanoma hist./un-
       & maint.treatm.               Drug interactions: Incr.levodopa C max & decr.T max, incr.AUC & half life   diag.skin les., pregn., women of child bear.age, not recomm.for drug-
       Restless leg syndr: Start.dos: 0,125 mg once dly.2-3 hrs.bef.bed-  with cimetidine, poss.interact. with amantidine, clear.decr.by drugs   induc. extrapyramid. reacts., safety in childr.bel.18 yrs./ lactat.not est.
       time. Dos.may be incr.every 4-7 days to max.0,75 mg/day if necess.  secret.by cation. transport syst., eff.poss.diminish.by dopamine an-  Side effects: Dyskines.incl.involunt.movem., psychiatr. sympt.,
       (S4) ER TABS, [P/S] 43/5.4.1/1062, 1063, 1064, 1065  tagon., poss.addit.effs.of CNS depress. & alcoh.  nausea, card.disturbs.incl., orthostat. hypotens./bradykinet.episod.,
       718253-001: 0,375 mg, 30, R449,75  REQUIP, (Aspen Pharmacare) GSK [P/S]  GI disturbs. incl.bleed., CNS effs., phlebit., bld. dyscras., dyspn.,
       718255-001: 0,75 mg, 30, R882,91  Ropinirole               chest pain, paraesthes., convuls., ataxia, incr.hand tremor, trismus,
       718256-001: 1,5 mg, 30, R958,45  Indications: Parkinson.dis.as early ther.when dopaminerg.ther.indi-  numbn., latent Horner’s syndr.activat., musc.cramp., hiccups, sialor-
       718257-001: 3,0 mg, 30, R1 395,47  cat./adjunct.treatm.to levodopa.  rhoea, dysphag., dry mouth, bitter taste, burn. tong., bruxism, weight
       Dosage: Parkinson’s dis: Admin.once dly.at same time. Swall.  (S4) XL PROLONG.RELEAS.TABS, 41/5.4.1/0604, 0606, 0607.  gain/loss., oed., dark. & incr.sweat., hair loss, flush., skin reacts., dark
       whole with water. Not to be crush./chew./div. If dos.miss.admin.up   711090-001: 2,0 mg, 28, R343,58  urine, urin.retent., priapism, incontin., vis.disturbs. incl.oculogyr.cris.,
       to 12 hrs. aft. reg.sched.time. Aft.12 hrs, miss.dos.to be left out &   711090-002: 2,0 mg, 42, R515,35  hoarsen., hot flush., stimulat., bizarre breath.patterns, neurolept.ma-
       next dos.taken on foll.day at next reg.sched. time.  711091-001: 4,0 mg, 28, R439,05  lign.syndr., malign.melanoma.
       Init: Dos.incr.grad.from start.dos.of 0,375 mg/day & then incr.every   711092-001: 8,0 mg, 28, R782,81  Special precautions: Teratogenicity in experim. animals, consid.
       7 days. Dos.titrat.to achiev.max. therap. eff.depend.on toler.  Dosage: Titrat.against effic.& tolerability. Admin. as sngl.dly dos.at   dos.reduc.with musc.twitch.& blepharosp., sev.CV/pulm.dis., bronch.
       Ascend.dos. sched: Wk 1: 0,375 mg/day, Wk 2: 0,75 mg/day, Wk   same time. Do not chew/ crush/div. If treatm.interrupt.for 1 day or   asthma, discont.levodopa 12 hrs.bef.start. Sinemet., ren./ liv./endocr.
       3: 1,50 mg/day. Dly dos.should be incr.by 0,75 mg at wkly.interv.up   more consid.re-init.by dos.titrat.  dis., MI hist., monit.for ment.chang., depress.with suic./ser.antisoc.
       to max. 4,5 mg/ day.if furth.dos.incr.necess. Pts.may be switch.from   Treatm.init: Tot.dly.dos: Wk.1: 2 mg. Wk 2: 4 mg. Wk.3: 6 mg.   behav., curr./sev. involunt.movem./psychot.episod.hist., withdr. grad.,
       IR to ER Tabs overnight at same dly. dos. if already taking immed.re-  Wk.4: 8 mg.  convuls.hist., monit.pts.on concom. neurolept. caref.if discont./reduc.
       lease tabs. Maint. ther: Indiv.dos.from 0,375 mg to max.of 4,5 mg/ day.  Therapeut.regimen: If suffic.sympt.contr.not achiev./maint.with init.  abrupt., chron. wide angle glauc., pept.ulc.hist.
       In concom.ther.reduc.levodopa dos.both dur. escalat. & maint.treatm.  titrat.dly.dos.may be incr. by increm.of upto 4 mg once every 1-2 wks.  Drug interactions:.Poss.postur.hypotens.with , anti-hypertens.,
       Contraindications: Childr.bel.18 yrs.not recomm., ER tabs: mod.to   upto max.24 mg once dly. When admin.as adjunct to L-dopa grad.  hypertens./dyskines.with TCA’s, phenothiaz.& butyrophenones
       sev.ren.funct.impairm., IR tabs sev.ren.impairm., safety in pregn.&   reduct.of L-dopa by approx.30% poss.  decr.eff., phenytoin, papaverine reverse anti-parkin.eff., high pro-
       lactat. not est.              Switch.from Requip tabs to Requip XL tabs: May be switch.  tein diet. decr.absorpt.
       Side effects: Somnol., drowsin.potent., psych. disords., insomn.,   overnight. Bas.XL tabs.dos.on tot. dly.dos.of Requip tabs.taken.
       restlessn., decr./incr.libido, dizzin., syncope, vis.impairm.incl.diplop.,   Then adjust to therapeut. respons. When switch.treatm.from anoth.  STALEVO, Novartis [P/S]
       pneumon., dyspn., hiccups, skin reacts., hallucinat. & confus.esp.in   dopamine agon.follow manufact. lit.on discontin.bef.init.Requip XL.  Levodopa 50 mg, carbidopa 12,5 mg, entacapone 200 mg
       elderly, hypersens., periph.oed., fatig., abnorm.behav., binge eat.,   Contraindications: Pregn.& lactat., hypersens.  Indications: Parkinson.dis.& end-of-dos.fluctat.
       hyperphag., patholog.gambling., hypersexuality, compuls. shopping,   Side effects: CNS effs.incl.somnol.& fall. asleep, syncope, postur.  (S4) TABS.50/12,5 [P/S] 38/5.4.1/0067.
       CNS effs., headache, dyskines., sudd. onset of sleep, hyperkines.,   hypotens.esp.dur.dos. escalat., psych.disords.incl.hallucinat.& suic.   707999-001: 100, R1 519,00
       weight chang., hypotens., GI disturbs., postur.(orthostat.) hypotens.  attempt, dyskines., incr.libido., confus., GI disturbs. incl. haemorrh.,   (S4) TABS.100/25, [P/S] 38/5.4.1/0138.
       Special precautions: Fall.asleep.dur.dly.liv. activ., re-assess.pts.  gen./periph.oed., infects. & infestat.incl.vir.infect./UTI/ URTI, neo-  Levodopa 100 mg, carbidopa 25 mg, entacapone 200 mg
       reg.for drowsin.& sleepin., pt. to be advis.of drowsin.potent.bef.init.  plasm/ benign/malign.unspec., haematol. effs. incl.lymphocytos.&vit.  708000-001: 100, R1 519,00
       treatm., concom. sedat.meds./exist.sleep disords.& concom. meds.  B12 defic., hypo/-hyperthyroid., SAIDH, hyper-/hypoglycaem., gout,   (S4) TABS.150/37,5, [P/S] 38/5.4.1/0137
       incr. pramipexole plasma lev., dos. reduct. may not reduc.fall.asleep   hyperphosphataem./-uricaem., diab. mellit., hypo-/hyperkalaem., aci-  Levodopa 150 mg, carbidopa 37,5 mg, entacapone 200 mg
       episod., poss. ther. discont.if signif.dayt.sleepin.esp.dur.activ. requir.   dos., hypercholesterolaem., hyponatraem., dehydrat., hypochloraem.,   708001-001: 100, R1 519,00
       act.particip., cons.dos.reduct./grad.discont. in case of behav.chang.  aggrav.Parkinsonism, hyper/-hypoton., abnorm.co-ordinat., extrapy-  Dosage: Tabs.to be swall.whole & taken as one dos. Titrate optim.
       eg.impulse contr.disords./ compuls. behav., alert.dr.if pregn.occurs/  ramid. disord., convuls.& hemipares., subarachnoid haemorrh., vis.  dly.dos.using one of strengths avail. Max.dos: 10 tabs/day.
       intend. becom. pregn.dur.ther., inhib.prolact.secret., ren. impairm.,   disturbs, vertigo, tinnit., bradycard., MI, CV effs.incl.supraventric. /  Switch.from entacapone & std.rel.levodopa/ carbidopa ther.
       warn.pts.esp.Parkinson pts.of poss. orthostat. hypotens.esp.dur.dos.  ventric. tachycard./ang.pect./bundle branch block/ card.arrest/cardio-  In dos.equal to a Stalevo tab strength: Switch direct.to corre-
       escalat., monit.for melanoma/ ophthalm.patholog.chang., inform.pts.   spond.Stalevo tab. In dos.not equal to a Stalevo tab strength:
       that (mostly vis.) hallucinat.may occur, somnol. incr. at dos.high.than   megaly/mitral insuffic., hot flush., aneurysm, varicose veins, phlebit.,   Titrate dos.to optimal clinic.respons.start.with dos. correspond.as
                                     periph. gangrene, limb embol., cough, resp./ thorac & mediastin.dis-
       1,5 mg/day, incr.CF risk, poss. potent.of dopaminerg.S/E of levodopa   closely as poss.to tot.levodopa dly. dos.used.
       caus./ exacerb. pre-exist.dyskines., monit.BP when init. ther., sev.CV   ords., hepatobil.disords., skin & subcutan.tiss.disords., incr.sweat.,   Switch.from entacapone & levodopa/ benserazide std rel.
                                     musculoskelet.& connect.tiss.disords., arthralg., back/ chest/skelet.
       dis., poss.neurolept.malign.syndr. with abrupt withdr.in Parkinson’s   formulat: Stop treatm.for one night and start Stalevo the.next
       dis., taper.grad. if discont.ther., RLS augmentat.phenomena (ie. ear-  pain, myalg., leg cramps, paraesthes., arthrit., musc.spasm, arthros.,   morn. Comm. with dos.provid.the same amnt levodopa or slightly
                                     osteoporos., polymyalg., musc.weakn., haematur., dysur., micturit.
       lier sympt.onset/incr.sympts.& spread of sympts. to other extremet.)   (5-10%) more.
       poss.but trials not of suffic. durat.to determ.augmentat., caut.pts.   freq., ren.& urin. disords. incl.ac.ren.fail, reproduct.syst.& breast   Switch.from control.release levodopa/ DDC inhibit.formulat:
       against rising rapid.aft.sitt./lying down for long per. esp.at treatm.init.  disords., fatig., pain, rigors, flu-like sympt., thirst, weight loss, falls.  Titrate caref.to optimal clinic. respons.
       Drug interactions: Cimetidine incr.plasma lev., poss.addit.effs.  Warnings and special precautions: Re-assess pts.contin.for   Switch.pts.not curr.treat.with entacapone: Consid.init.ther.at
       of CNS depress. & alcoh., poss. potent levodopa dopaminerg.S/E,   sleepin./drowsin., poss.fall. asleep.dur.dly.liv.activ., compuls. gam-  dos.correspond.to curr.treatm.if not stabilis.on curr.std.rel.levodopa/
       clear.decr.by drugs secret.by cation.transport syst., eff.poss. dimin-  bling report., warn.pt.of syncope assoc. with bradycard./poss.or-  DDC inhibit. treatm.
       ish.by dopamine antagonist.   thostat. hypotens./ drowsin. developm./ hallucinat./concom.meds.   Direct switch not recomm.for pts.with dyskinesias/ where dly.levo-
                                     that incr. ropinirole plasma lev., caref.monit.for postur. hypotens.   dopa dos.above 800 mg/day. In such pts. introd. entacapone treatm.
       PRAMEX, (Ascendis Pharma) Akacia [P/S]  S&S esp.dur.dos.escalat., dyskines. poss.caus./exacerbat.by potent.   as separat.med. adjust. levodopa dos.if necess.bef.init.Stalevo as
       Pramipexole dihydrochlor.monohydr.  dopaminerg.S/E of L-dopa, elderly, sev.CV dis., outweigh benef.-risk   entacapone enhanc.levodopa effs.</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page73.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page69.html">69</a>&nbsp;&nbsp;&nbsp;<a href="page70.html">70</a>&nbsp;&nbsp;&nbsp;<a href="page71.html">71</a>&nbsp;&nbsp;&nbsp;<a href="page72.html">72</a>&nbsp;&nbsp;&nbsp;<a href="page73.html">73</a>&nbsp;&nbsp;&nbsp;<a href="page74.html">74</a>&nbsp;&nbsp;&nbsp;<a href="page75.html">75</a>&nbsp;&nbsp;&nbsp;<a href="page76.html">76</a>&nbsp;&nbsp;&nbsp;<a href="page77.html">77</a>&nbsp;&nbsp;&nbsp;<a href="page78.html">78</a>&nbsp;&nbsp;&nbsp;<a href="page79.html">79</a>
             </td>
             <td width="35%"><a href="page75.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page75.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
